AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

 8,842.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 9,444.00
  • 52 Week Low: 6,794.00
  • Currency: UK Pounds
  • Shares Issued: 1,549.40m
  • Volume: 0
  • Market Cap: £136,998m
  • RiskGrade: 123
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
85.56% above the market average85.56% above the market average85.56% above the market average85.56% above the market average85.56% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr Revenue Growth
36.19% above the market average36.19% above the market average36.19% above the market average36.19% above the market average36.19% above the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
11.54% below the market average11.54% below the market average11.54% below the market average11.54% below the market average11.54% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
89.87% below the market average89.87% below the market average89.87% below the market average89.87% below the market average89.87% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
27.76% above the market average27.76% above the market average27.76% above the market average27.76% above the market average27.76% above the market average
52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average
Price Chg 3m
26.25% above the market average26.25% above the market average26.25% above the market average26.25% above the market average26.25% above the market average
58.73% above the sector average58.73% above the sector average58.73% above the sector average58.73% above the sector average58.73% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
43.36% above the market average43.36% above the market average43.36% above the market average43.36% above the market average43.36% above the market average
83.61% above the sector average83.61% above the sector average83.61% above the sector average83.61% above the sector average83.61% above the sector average
Momentum 20
97.78% above the market average97.78% above the market average97.78% above the market average97.78% above the market average97.78% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
38.17% above the market average38.17% above the market average38.17% above the market average38.17% above the market average38.17% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average
ROCE
84.91% above the market average84.91% above the market average84.91% above the market average84.91% above the market average84.91% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
97.58% above the market average97.58% above the market average97.58% above the market average97.58% above the market average97.58% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Forecast EPS
96.95% above the market average96.95% above the market average96.95% above the market average96.95% above the market average96.95% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.03% above the market average97.03% above the market average97.03% above the market average97.03% above the market average97.03% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average
Operating Profit Loss
98.80% above the market average98.80% above the market average98.80% above the market average98.80% above the market average98.80% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Cash
97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
3.31% below the market average3.31% below the market average3.31% below the market average3.31% below the market average3.31% below the market average
9.52% above the sector average9.52% above the sector average9.52% above the sector average9.52% above the sector average9.52% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
0.42% above the market average0.42% above the market average0.42% above the market average0.42% above the market average0.42% above the market average
44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average
Brokers Percent Neutral
97.88% below the market average97.88% below the market average97.88% below the market average97.88% below the market average97.88% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,842.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 9,444.00
52 Week Low 6,794.00
Volume 0
Shares Issued 1,549.40m
Market Cap £136,998m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.03% below the market average88.03% below the market average88.03% below the market average88.03% below the market average88.03% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average
Price Trend
46.79% above the market average46.79% above the market average46.79% above the market average46.79% above the market average46.79% above the market average
61.90% above the sector average61.90% above the sector average61.90% above the sector average61.90% above the sector average61.90% above the sector average
Income
53.07% below the market average53.07% below the market average53.07% below the market average53.07% below the market average53.07% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Growth
86.33% above the market average86.33% above the market average86.33% above the market average86.33% above the market average86.33% above the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average

What The Brokers Say

Strong Buy 23
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 28
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 12-Aug-21 25-Feb-21
Paid 13-Sep-21 29-Mar-21
Amount 90.00¢ 190.00¢

Trades for --2022

Time Volume / Share Price
0 @ 0.000p

Top of Page